Gout, not induced by diuretics? A case-control study from primary care

Annals of the Rheumatic Diseases

Volumn 65, Issue 8, 2006, Pages 1080-1083

  Janssens, H J E M ^a   Van De Lisdonk, E H ^a   Janssen, M ^b   Van Den Hoogen, H J M ^a   Verbeek, A L M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GOUT; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

ADULT; AGED; CASE-CONTROL STUDIES; DIURETICS; FEMALE; GOUT; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 33746535564     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.040360     Document Type: Article

References (34)

1. Humphreys DM. Acute gout apparantly precipitated by furosemide. BMJ 1966;1:1024-5.
2. Bieber JD, Terkeltaub RA. Gout: on the brink of novel therapeutic options for an ancient disease. Arthritis Rheum 2004;50:2400-14.
3. Pascual E. Management of crystal arthritis. Reumatology (Oxford) 1999;38:912-6.
4. European Society of Hypertension. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.
5. World Health Organization. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999;17:151-83.
6. College van Zorgverzekeringen. Geneesmiddelen Informatie Project. Available from, http://www.gipdatabank.nl/ (accessed 15 April 2006).
7. Abbott RD, Brand FN, Kannel WB, Castelli WP. Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol 1988;41:237-42.
8. Hochberg MC, Thomas J, Thomas DJ, Mead L, Levine DM, Klag MJ. Racial differences in the incidence of gout. The role of hypertension. Arthritis Rheum 1995;38:628-32.
9. Janssens HJEM, van de Lisdonk EH, Bor H, van den Hoogen HJ, Janssen M. Gout, just a nasty event or a cardiovascular signal? A study from primary care. Fam Pract 2003;20:413-16.
10. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003;41:1183-90.
11. Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension 2003;42:247-52.
12. Leyva F, Anker S, Swan JW, Godsland IF, Wingrove CS, Chua TP, et al. Serum uric acid as an index of impaired oxidative metabolisme in chronic heart failure. Eur Heart J 1997;18:858-65.
13. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, et al. Uric acid and survival in chronic heart Failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003;107:1991-7.
14. Hare JM, Johnson RJ. Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology. Circulation 2003;107:1951-3.
15. Wannamethee SG, Shaper AG, Whincup PH. Serum urate and the risk of major coronary heart disease events. Heart 1997;78:147-53.
16. Terkeltaub RA. Gout. N Engl J Med 2003;349:1647-55.
17. Macfarlane DG, Dieppe PA. Diuretic-induced gout in elderly women. Br J Rheumatol 1985;24:155-7.
18. Scott JT, Higgens CS. Diuretic induced gout: a multifactorial condition. Ann Rheum Dis 1992;51:259-61.
19. Berglund G, Andersson O, Widgren B. Low-dose antihypertensive treatment with a thiazide diuretic is not diabetogenic. A 10-year controlled trial with bendroflumethiazide. Acta Med Scand 1980;220:419-24.
20. Langford HG, Blaufox MD, Borhani NO, Curb JD, Molteni A, Schneider KA, et al. Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program. Arch Intern Med 1987;147:645-9.
21. Fletcher AE. Adverse treatment effects in the trial of the European Working Party on High Blood Pressure in the Elderly. Am J Med 1991;90(3A):42S-4S.
22. Staessen J. The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial. Am J Med 1991;90(3A):50S-4S.
23. Gurwitz JH, Kalish SC, Bohn RL, Glynn RJ, Monane M, Mogun H, et al. Thiazide diuretics and the initiation of anti-gout therapy. J Clin Epidemiol 1997;50:953-9.
24. Lin KC, Lin Hy, Chou P. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hypeuricemic men in a prospective study. J Rheumatol 2000;27:1501-5.
25. Classification Committe of WONCA. ICHPPC-2 defined, 3rd ed. Oxford: Oxford University Press, 1983.
26. World Health Organisation. The Anatomical Therapeutic Chemical Classification System with Defined Daily Doses (ATC/DDD). Available from, http://www.who.int/classifications/atcddd/en/print.html (accessed 15 April 2006).
27. Wallace SL, Robbinson H, Masi AT, Decker JL, McArty DJ, Yü T. Preliminary criteria for the classification of the acute arthritis of primary gout. Artritis Rheum 1977;20:895-900.
28. Dutch College of General Practitioners. NHG-standaarden Hypertensie, Hartfalen, Coronair Syndroom, Angina pectoris, TIA, CVA en PAV. Available from, http://nhg.artsennet.nl/content/resources/AMGATE_6059_104_TICH_L748581710/ AMGATE_6059_104_TICH_R119952487066081// (accessed 15 April 2006).
29. Ottervanger JP, van Witsen TB, Valkenburg HA, Grobbee DE, Stricker BH. Adverse reactions attributed to sumatriptan. A postmarketing study in general practice. Eur J Clin Pharmacol 1994;47:305-9.
30. Miettinen OS. Estimability and estimation in case-referent studies. Am J Epidemiol 1976;103:226-35.
31. Lisdonk EH, Van den Bosch WJHM, Huygen FJA, Lagro-Jansen ALM. Ziekten in de huisartspraktijk [Diseases in general practice]. Maarssen: Elsevier, 2003.
32. Gorter KJ, Tan G, Verstappen WHJM, Cirkel JW, Kolnaar BGM, Osterberg E, et al. NHG-standaard Jicht [gout]. Available from, http://nhg.artsennet.nl/ upload/104/guidelines2/E72.htm#noot4 (accessed 15 April 2006).
33. Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents. A network meta-analysis. JAMA 2003;289:2534-44.
34. Faris R, Flather M, Purcell H, Henein M, Poole-Wilson P, Coats A. Current evidence supporting the role of diuretics in heart failure: a meta-analysis of randomised controlled trials. Int J Cardiol 2002;82:149-58.